Jun 1, 2011 | Press release
Jun. 1, 2011 (Business Wire) — Molecular Response (MRL), a privately held molecular diagnostic services company and a leader in the identification of target populations for high value therapeutics, announced today a joint discovery/development agreement with Scripps...
